Type 1 Diabetes

Type 1 Diabetes: Introduction

Type 1 Diabetes: Introduction

Type 1 diabetes is estimated to affect roughly 300,000 individuals across Canada . Though often conflated with type 2 diabetes in public health surveys and casual discourse, its risk factors, etiology, and patient population are distinct from those of type 2 diabetes […]

Type 1 Diabetes: Key Messages

Type 1 Diabetes: Key Messages

Significant reductions in hemoglobin A1c (HbA1c) are reported frequently enough to support claims that home telehealth can be as or more effective than usual care in improving glycemic control.  However, many studies that do not report significant differences between telehealth and usual care.  In short, there is strong evidence that home telehealth can be very […]

Type 1 Diabetes: Scope of Literature

Type 1 Diabetes: Scope of Literature

Summary This review sought to collect and interpret the evidence base on home telehealth in managing type 1 diabetes. We looked at three areas: Patients: How is home telehealth used in care management for people with type 1 diabetes?  Do patients like it?  How clinically effective is it?  Providers: What is the impact of home […]

Type 1 Diabetes: Intervention Design and Implementation

Type 1 Diabetes: Intervention Design and Implementation

Summary Home telehealth is used to support the management of type 1 diabetes in a number of ways.  Its most frequent embodiment is as a remote monitoring service.  Patients upload their blood glucose values to a provider-accessible server and receive feedback that assists them in managing their condition.  Target populations tend consist of patient with […]

Type 1 Diabetes: Patient Outcomes

Type 1 Diabetes: Patient Outcomes

Summary There is strong evidence that home telehealth has the potential to lower hemoglobin A1c (HbA1c), generally without increasing frequency of hypoglycemia.  There is also strong evidence that this reduction can be significantly greater than that achieved with usual care.  This outcome may be due in part to improvements in disease knowledge and increased frequency […]

Type 1 Diabetes: Provider Outcomes

Type 1 Diabetes: Provider Outcomes

Summary Descriptions of the types of providers involved in home telehealth for type 1 diabetes are scarce.  When given, they tend to be cursory.  Findings from other chronic diseases would suggest that nurses are usually responsible for patient contact and case management, but the evidence does not allow us to state this with certainty.  Physicians […]

Type 1 Diabetes: System Outcomes

Type 1 Diabetes: System Outcomes

Summary The economic effects of home telehealth can be discussed using direct or indirect measures of costs and cost savings.  Direct measures include figures such as cost per patient, cost per telehealth unit, and annual costs.  Examples of indirect measures are probability of patient hospitalization, number of emergency room visits, and other types of health […]

Type 1 Diabetes: Works Cited

Type 1 Diabetes: Works Cited

Albisser AM, Wright CE., Sakkal S. (2007), Averting iatrogenic hypoglycemia through glucose prediction in clinical practice: Progress towards a new procedure in diabetes, Diabetes Research and Clinical Practice, 76: 207-214 Benhamou PY, Melki V., Boizel R, Perreal F, Quesada J:, Bessieres-Lacombe S, Bosson JL, Halimi S, Hanaire H. (2007), 1 year efficacy and safety of […]

Type 1 Diabetes: Master Table

Type 1 Diabetes: Master Table

 Click on a column’s arrow to sort by that column.  To view a larger version of the table, click on the icon in its lower right corner. See also Type 1 Diabetes – Works Cited.